吉林敖东(000623.SZ)：硫酸特布他林雾化吸入用溶液完成药品注册

Core Viewpoint - Jilin Aodong (000623.SZ) announced that its subsidiary, Jilin Aodong Pharmaceutical Group Yanji Co., Ltd. (referred to as "Yanji Pharmaceutical"), has received the "Drug Registration Certificate" for "Sulbutamol Sulfate Nebulized Inhalation Solution" from the National Medical Products Administration [1] Group 1 - The indication for Sulbutamol Sulfate Nebulized Inhalation Solution is to relieve bronchial asthma, chronic bronchitis, emphysema, and other pulmonary diseases associated with bronchospasm [1]